Benjamin Looker, Chief Legal Officer at Esperion Therapeutics, Inc. (ESPR), sold 11,416 shares at $2.70 ($31K) on 2026-03-17, disclosed to the SEC on 2026-03-18.
Seasonal sale ($31k) by Chief Legal Officer — this insider has traded ESPR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.70 | 5,708 | $15K | 50.0% |
| 2 | $2.70 | 5,708 | $15K | 50.0% |
| Total | $2.70 avg | 11,416 | $31K | 100% |
| Filing → |
| ESPR | SELL | 2025-12-18 | $24K | — | Filing → |
| ESPR | SELL | 2025-10-20 | $3K | — | Filing → |
| ESPR | SELL | 2025-09-18 | $18K | — | Filing → |